Exchange agreementExchange Agreement • March 14th, 2024 • Unicycive Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 14th, 2024 Company Industry JurisdictionThis Exchange Agreement (this “Agreement”) is made as of March 13, 2024, by and among Unicycive Therapeutics, Inc., a Delaware corporation (the “Company”), and the holder of shares of Series A Preferred Stock (as defined in the Current Charter) listed on Exhibit A attached hereto (such shares the “Surrendered Shares” and the holder, the “Exchanging Holder”).